press release details

Press Releases

Lam Research Corporation Reports Financial Results for the Quarter Ended June 30, 2013

View PDF

FREMONT, CA -- (Marketwired) -- 07/31/13 -- Lam Research Corp. (NASDAQ: LRCX) today announced financial results for the quarter ended June 30, 2013.

Highlights for the June 2013 quarter were as follows:

  • Shipments of $1,080 million, up 21% from the prior quarter
     
  • Revenue of $986 million, up 17% from the prior quarter
     
  • GAAP gross margin of 42.0%, GAAP operating margin of 8.8% and GAAP diluted EPS of $0.50
     
  • Non-GAAP gross margin of 44.5%, non-GAAP operating margin of 14.4%, and non-GAAP diluted EPS of $0.80
     
  
Financial Highlights for the Quarters Ended June 30, 2013 and March 31, 2013 
(in thousands, except per-share data and percentages) 
          
U.S. GAAP 
  June 2013  March 2013  Change Q/Q 
            
Revenue $986,214  $844,928  +17%
Gross margin as percentage of revenue  42.0%  40.2% +180 bps 
Operating margin as percentage of revenue  8.8%  1.3% +750 bps 
Diluted EPS $0.50  $0.11  +355%
            
Non-GAAP 
  June 2013  March 2013  Change Q/Q 
            
Revenue $986,214  $844,928  +17%
Gross margin as percentage of revenue  44.5%  43.9% +60 bps 
Operating margin as percentage of revenue  14.4%  8.8% +560 bps 
Diluted EPS $0.80  $0.44  +82%
            
 

GAAP Financial Results

Revenue for the period was $986.2 million, gross margin was $413.9 million, or 42.0% of revenue, operating expenses were $327.4 million, and net income was $85.7 million, or $0.50 per diluted share on a GAAP basis. This compares to revenue of $844.9 million, gross margin of $339.8 million, or 40.2% of revenue, operating expenses of $329.0 million, and net income of $19.0 million, or $0.11 per diluted share, for the March 2013 quarter.

Non-GAAP Financial Results

Non-GAAP gross margin was $438.8 million, or 44.5% of revenue, non-GAAP operating expenses were $297.0 million, and non-GAAP net income was $136.4 million, or $0.80 per diluted share. This compares to non-GAAP gross margin of $370.7 million, or 43.9% of revenue, non-GAAP operating expenses of $296.0 million, and non-GAAP net income of $74.5 million, or $0.44 per diluted share, for the March 2013 quarter.

"Lam Research had a very strong June 2013 quarter, achieving record shipments and revenue and delivering EPS performance that exceeded our guidance range," said Martin Anstice, Lam's president and chief executive officer. "Our results underscore our strong operational execution and commitment to invest strategically to address our customers' most critical problems and further strengthen our competitive positions. We believe we will benefit from market expansion opportunities and that our focus on technology and productivity innovation positions us well for next-generation technology inflections and investments planned by our customers."

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investment balances increased to $2.7 billion at the end of the June 2013 quarter compared to $2.5 billion at the end of the March 2013 quarter. Cash flows from operating activities were approximately $175 million during the June 2013 quarter, adding to our overall cash position.

Deferred revenue and deferred profit balances at the end of the June 2013 quarter increased to $389.2 million and $225.0 million, respectively, as compared to $326.6 million and $193.3 million, respectively, at the end of the March 2013 quarter. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $69.9 million as of June 30, 2013.

Geographic Distribution

The geographic distribution of shipments and revenue during the June 2013 quarter is shown in the following table:

     
Region Shipments Revenue
North America 13% 15%
Europe 7% 8%
Japan 13% 11%
Korea 20% 17%
Taiwan 32% 33%
Asia Pacific 15% 16%
     
 

Outlook

For the September 2013 quarter, Lam is providing the following guidance on a non-GAAP basis:

  • Shipments of approximately $1 billion plus or minus $30 million
  • Revenue of approximately $1 billion plus or minus $30 million
  • Gross margin of approximately 44.0% plus or minus 1.0%
  • Operating margin as a percent of revenue of approximately 14.0% plus or minus 1.5%
  • Earnings per share of approximately $0.68 plus or minus $0.07, based on a diluted share count of 170 million

Use of Non-GAAP Financial Results

In addition to U.S. GAAP results, this commentary also contains non-GAAP financial results. The Company's non-GAAP results for both the June 2013 and March 2013 quarters exclude costs associated with the fair-value impact of acquisition-related inventory, amortization related to intangible assets acquired in the Novellus transaction, certain integration-related costs, the amortization of convertible note discounts, rationalization of certain product configurations, and tax expense associated with legal-entity integration. Additionally, the June 2013 quarter non-GAAP results exclude restructuring charges and tax benefits from the successful resolution of certain tax matters, and the March 2013 quarter non-GAAP results exclude the impairment of an investment and tax benefit on reinstatement of R&D tax credit.

Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing the investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company's web site at http://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to, the anticipated revenue from shipments to Japanese customers, our future competitive positioning, our ability to benefit from market expansion opportunities and next generation technology investments, and our guidance for shipments, revenue, gross margin, operating margin, and earnings per share. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy; the strength of the financial performance of our existing and prospective customers; the introduction of new and innovative technologies; the occurrence and pace of technology transitions and conversions; the actions of our competitors, consumers, semiconductor companies and key suppliers and subcontractors; and the success of research and development and sales and marketing programs. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed by us with the Securities and Exchange Commission, including specifically our report on Form 10-K for the year ended June 24, 2012 and Form 10-Qs for the three months ended September 23, 2012, December 23, 2012, and March 31, 2013. These uncertainties and changes could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

About Lam Research

Lam Research Corp. (NASDAQ: LRCX) is a trusted global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's broad portfolio of market-leading etch, deposition, strip, and wafer cleaning solutions help customers achieve success on the wafer by enabling device features that are 1,000 times smaller than a grain of sand, resulting in smaller, faster, and more power-efficient chips. Through collaboration, continuous innovation and delivering on commitments, Lam is transforming atomic-scale engineering and enabling our customers to shape the future of technology. Based in Fremont, Calif., Lam Research is an S&P 500® company whose common stock trades on the NASDAQ Global Select Market under the symbol LRCX. For more information, please visit http://www.lamresearch.com.

Consolidated Financial Tables Follow.

  
LAM RESEARCH CORPORATION 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
(in thousands, except per share data and percentages) 
                
  Three Months Ended  Twelve Months Ended 
  June 30,  March 31,  June 24,  June 30,  June 24, 
  2013  2013  2012  2013  2012 
  (unaudited)  (unaudited)  (unaudited)  (unaudited)  (1) 
Revenue $986,214  $844,928  $741,814  $3,598,916  $2,665,192 
                     
 Cost of goods sold  572,287   505,096   443,601   2,195,857   1,581,982 
 Cost of goods sold - restructuring and impairments  -   -   -   -   (859)
  Total costs of goods sold  572,287   505,096   443,601   2,195,857   1,581,123 
  Gross margin  413,927   339,832   298,213   1,403,059   1,084,069 
  Gross margin as a percent of revenue  42.0%  40.2%  40.2%  39.0%  40.7%
Research and development  180,220   174,206   124,528   683,688   444,559 
Selling, general and administrative  146,417   154,807   141,015   599,487   400,052 
Restructuring and impairments  792   -   -   1,813   1,725 
  Total operating expenses  327,429   329,013   265,543   1,284,988   846,336 
  Operating income  86,498   10,819   32,670   118,071   237,733 
  Operating margin as a percent of revenue  8.8%  1.3%  4.4%  3.3%  8.9%
Other expense, net  (12,251)  (15,834)  (9,889)  (51,413)  (33,315)
  Income (loss) before income taxes  74,247   (5,015)  22,781   66,658   204,418 
Income tax expense (benefit)  (11,460)  (24,011)  4,712   (47,221)  35,695 
  Net income $85,707  $18,996  $18,069  $113,879  $168,723 
Net income per share:                    
 Basic net income per share $0.53  $0.12  $0.13  $0.67  $1.36 
 Diluted net income per share $0.50  $0.11  $0.13  $0.66  $1.35 
Number of shares used in per share calculations:                    
 Basic  162,520   163,034   133,997   168,932   124,176 
 Diluted  169,722   168,504   135,842   173,430   125,233 
                     
                     
(1) Derived from audited financial statements 
 
 
 
 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
       
  June 30, March 31, June 24,
  2013 2013 2012
  (unaudited) (unaudited) (1)
ASSETS         
Cash and cash equivalents $1,162,473 $1,019,109 $1,564,752
Short-term investments  1,334,745  1,337,819  1,297,931
Accounts receivable, net  602,624  544,070  765,818
Inventories  559,317  545,036  632,853
Deferred income taxes  27,674  137,729  47,782
Other current assets  106,996  86,156  105,973
 Total current assets  3,793,829  3,669,919  4,415,109
Property and equipment, net  603,910  594,916  584,596
Restricted cash and investments  166,536  166,196  166,335
Goodwill and intangible assets  2,526,541  2,562,986  2,686,730
Other assets  159,499  152,285  151,882
 Total assets $7,250,315 $7,146,302 $8,004,652
          
LIABILITIES AND STOCKHOLDERS' EQUITY         
Current liabilities $1,404,475 $801,013 $1,426,928
          
Long-term debt and capital leases $789,256 $1,294,599 $761,783
Income taxes payable  246,479  250,339  274,240
Other long-term liabilities  134,313  258,151  219,577
 Total liabilities $2,574,523 $2,604,102 $2,682,528
          
Senior convertible notes  186,920  -  190,343
          
Stockholders' equity (2)  4,488,872  4,542,200  5,131,781
 Total liabilities and stockholders' equity $7,250,315 $7,146,302 $8,004,652
          
(1) Derived from audited financial statements
          
(2) Common shares issued and outstanding were 162,873 as of June 30, 2013, 161,802 shares as of March 31, 2013, and 186,656 shares as of June 24, 2012.
          
 
  
  
LAM RESEARCH CORPORATION 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
(in thousands) 
                
  Three Months Ended  Twelve Months Ended 
  June 30,  March 31,  June 24,  June 30,  June 24, 
  2013  2013  2012  2013  2012 
  (unaudited)  (unaudited)  (unaudited)  (unaudited)  (1) 
CASH FLOWS FROM OPERATING ACTIVITIES:                    
Net income $85,707  $18,996  $18,069  $113,879  $168,723 
Adjustments to reconcile net income to net cash provided by operating activities:                    
 Depreciation and amortization  76,051   74,861   34,576   304,116   100,825 
 Deferred income taxes  (22,884)  (27,934)  39,356   (70,155)  42,446 
 Restructuring charges, net  792   -   -   1,813   866 
 Equity-based compensation expense  25,241   25,648   29,174   99,330   81,559 
 Income tax benefit on equity-based compensation plans  364   (847)  1,429   (483)  1,510 
 Excess tax benefit on equity-based compensation plans  (364)  903   (394)  539   (2,686)
 Impairment of investment  -   3,711   -   3,711   1,724 
 Amortization of convertible note discount  8,028   7,935   7,014   31,558   27,028 
 Other, net  4,550   6,115   7,206   35,388   10,877 
 Changes in operating asset and liabilities:  (2,497)  (6,931)  (39,715)  200,237   66,156 
  Net cash provided by operating activities  174,988   102,457   96,715   719,933   499,028 
                     
CASH FLOWS FROM INVESTING ACTIVITIES:                    
Capital expenditures and intangible assets  (43,140)  (34,766)  (36,880)  (160,795)  (107,272)
Cash acquired in (paid for) business acquisition  (800)  (400)  418,681   (9,916)  418,681 
Net sales/maturities (purchases) of available-for-sale securities  (6,442)  (12,075)  329,689   (58,405)  (41,989)
Purchase of equity method investment  -   -   -   -   (10,740)
(Issuance) repayments of notes receivable  (10,000)  -   -   (10,000)  8,375 
Proceeds from sale of assets  -   -   -   660   2,677 
Transfer of restricted cash and investments  (328)  (32)  (29)  (181)  (6)
  Net cash provided by (used for) investing activities  (60,710)  (47,273)  711,461   (238,637)  269,726 
                     
CASH FLOWS FROM FINANCING ACTIVITIES:                    
Principal payments on long-term debt and capital lease obligations  (698)  (756)  (1,101)  (2,234)  (5,265)
Excess tax benefit on equity-based compensation plans  364   (903)  394   (539)  2,686 
Treasury stock purchases  (2,275)  (243,297)  (661,059)  (955,661)  (772,663)
Net cash received in settlement of stock repurchase contracts  -   -   -   -   55,194 
Reissuances of treasury stock related to employee stock purchase plan  12,846   8,494   8,765   31,265   25,525 
Proceeds from issuance of common stock  16,713   15,132   -   39,379   1,776 
  Net cash provided by (used for) financing activities  26,950   (221,330)  (653,001)  (887,790)  (692,747)
Effect of exchange rate changes on cash  2,136   (4,934)  (690)  4,215   (3,387)
Net increase (decrease) in cash and cash equivalents  143,364   (171,080)  154,485   (402,279)  72,620 
Cash and cash equivalents at beginning of period  1,019,109   1,190,189   1,410,267   1,564,752   1,492,132 
Cash and cash equivalents at end of period $1,162,473  $1,019,109  $1,564,752  $1,162,473  $1,564,752 
                     
(1) Derived from audited financial statements 
 
  
  
  
Non-GAAP Financial Summary 
(in thousands, except percentages and per share data) 
(unaudited) 
       
  Three Months Ended  Three Months Ended 
  June 30,  March 31, 
  2013  2013 
         
Revenue $986,214  $844,928 
Gross margin $438,823  $370,658 
Gross margin as percentage of revenue  44.5%  43.9%
Operating expenses $297,048  $296,002 
Operating income $141,775  $74,656 
Operating margin as a percentage of revenue  14.4%  8.8%
Net income $136,440  $74,474 
Net income per diluted share $0.80  $0.44 
Shares used in per share calculation - diluted  169,722   168,504 
         
 
  
  
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income 
(in thousands, except per share data) 
(unaudited) 
       
  Three Months Ended  Three Months Ended 
  June 30,  March 31, 
  2013  2013 
U.S. GAAP net income $85,707  $18,996 
Pre-tax non-GAAP items:        
 Costs associated with rationalization of certain product configurations - cost of goods sold  (896)  207 
 Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold  20,748   20,763 
 Acquisition-related inventory fair-value impact - cost of goods sold  4,266   7,448 
 Integration costs - cost of goods sold  778   2,408 
 Integration costs - operating expenses  9,579   13,123 
 Amortization related to intangible assets acquired in Novellus transaction - operating expenses  18,888   19,445 
 Restructuring charges - operating expenses  792   - 
 Costs associated with rationalization of certain product configurations - operating expenses  1,122   443 
 Amortization of convertible note discount, Lam notes - other expense, net  7,159   7,075 
 Amortization of convertible note discount, Novellus assumed notes - other expense, net  781   893 
 Impairment of investment - other expense, net  -   3,711 
Net tax benefit on non-GAAP items  (10,252)  (11,700)
Net tax benefit on successful resolution of certain tax matters  (2,699)  - 
Tax benefit on reinstatement of R&D tax credit  -   (11,493)
Tax expense associated with legal-entity integration  467   3,155 
Non-GAAP net income $136,440  $74,474 
Non-GAAP net income per diluted share $0.80  $0.44 
Number of shares used for diluted per share calculation  169,722   168,504 
         
 
  
  
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income 
(in thousands, except percentages) 
(unaudited) 
       
  Three Months Ended  Three Months Ended 
  June 30,  March 31, 
  2013  2013 
U.S. GAAP gross margin $413,927  $339,832 
Pre-tax non-GAAP items:        
 Costs associated with rationalization of certain product configurations - cost of goods sold  (896)  207 
 Amortization related to intangible assets acquired in Novellus transaction - cost of goods sold  20,748   20,763 
 Acquisition-related inventory fair-value impact - cost of goods sold  4,266   7,448 
 Integration costs - cost of goods sold  778   2,408 
Non-GAAP gross margin $438,823  $370,658 
U.S. GAAP gross margin as a percentage of revenue  42.0%  40.2%
Non-GAAP gross margin as a percentage of revenue  44.5%  43.9%
U.S. GAAP operating expenses $327,429  $329,013 
Pre-tax non-GAAP items:        
 Integration costs - operating expenses  (9,579)  (13,123)
 Amortization related to intangible assets acquired in Novellus transaction - operating expenses  (18,888)  (19,445)
 Restructuring charges - operating expenses  (792)  - 
 Costs associated with rationalization of certain product configurations - operating expenses  (1,122)  (443)
Non-GAAP operating expenses $297,048  $296,002 
Non-GAAP operating income $141,775  $74,656 
Non-GAAP operating margin as a percent of revenue  14.4%  8.8%
         
 

Lam Research Corporation Contacts:
Shanye Hudson
Investor Relations
phone: 510-572-4589
e-mail: shanye.hudson@lamresearch.com

Ed Rebello
Corporate Communications
phone: 510-572-6603
e-mail: edward.rebello@lamresearch.com

Source: Lam Research Corporation

 

News Provided by Acquire Media